Request page removalAbout Eli Lilly
Eli Lilly is an entrepreneur and an angel investor based out of United States. Their journey in the startup ecosystem started in 1876 through Lilly. Eli Lilly has founded 1 company. They are currently acting as the founder of Lilly. As an angel investor, Eli Lilly has a portfolio of 15 companies, focusing primarily on sectors like Life Sciences, Enterprise Applications and 4 more sectors. They invest in companies across United States, China and 1 more. Their most notable investments include companies like Schrodinger and Monte Rosa Therapeutics.
Key Metrics
Location
Founded
Investment Portfolio
Top sectors of Investment
Top locations of Investment
Eli Lilly's Investments
Eli Lilly has invested in 15 companies. Their most recent investment was in Breezebio (Series A Round) on Jan 17, 2024. Their investments are primarily in Life Sciences, Enterprise Applications and 4 more sectors. Their investment portfolio include companies in United States, China and 1 more.Here are the details of all recent investments by Eli Lilly:
Date | Company | Round | Round Amount | Co-Investors |
|---|---|---|---|---|
Jan 17, 2024 | Series A | $24M | ||
Jun 22, 2023 | Series B | $52.9M | ||
Sep 23, 2021 | Series A | $26M | and 10 more |
Want to explore profiles similar to Eli Lilly?
Let us walk you through our investor database and other offerings.
Let us walk you through our investor database and other offerings.
Eli Lilly's Portfolio Exits
Eli Lilly has 8 Portfolio Exits including Schrodinger, Monte Rosa Therapeutics, Korro Bio and Arcellx.
Here is the list of top portfolio exits by Eli Lilly:
Company | Description | Location | Total Funding | Founded Year | Exit Type | Exit Date |
|---|---|---|---|---|---|---|
Provider of a web-based simulation and modelling tool | New York City (United States) | $162M | 1990 | IPO | Feb 06, 2020 | |
Developer of small molecule therapeutics to treat cancer | Cambridge (United States) | $224M | 2020 | IPO | Jun 24, 2021 | |
Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | Cambridge (United States) | $4M | 2018 | IPO | Oct 03, 2019 | |
Developer of T cell-mediated anti tumour therapy | Rockville (United States) | $205M | 2014 | IPO | Feb 04, 2022 |
Eli Lilly's Founded Companies
Eli Lilly has founded Lilly.
Here is the detail of this founded company:
Company | Short Description | Total Funding | Founded Year | Current Stage | Location |
|---|---|---|---|---|---|
Developer of traditional pharmaceutical medicines | - | 1876 | Public | Indianapolis |
FAQs about Eli Lilly
Recently updated other profiles
